ConductScience.org, home

Trial · NCT02777385

Adverse events722

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnemiaBlood and lymphatic system disordersCisplatin + Radiation + Pembrolizumab - Concurrent3241
otherAnemiaBlood and lymphatic system disordersCisplatin + Radiation + Pembrolizumab - Sequential3439
otherBlood and lymphatic system disorders - Other, specifygranulomatous lymphadenitisBlood and lymphatic system disordersCisplatin + Radiation + Pembrolizumab - Concurrent041
otherBlood and lymphatic system disorders - Other, specifygranulomatous lymphadenitisBlood and lymphatic system disordersCisplatin + Radiation + Pembrolizumab - Sequential139
otherBlood and lymphatic system disorders - Other, specifyvenous thrombosisBlood and lymphatic system disordersCisplatin + Radiation + Pembrolizumab - Concurrent141
otherBlood and lymphatic system disorders - Other, specifyvenous thrombosisBlood and lymphatic system disordersCisplatin + Radiation + Pembrolizumab - Sequential039
otherAcute coronary syndromeCardiac disordersCisplatin + Radiation + Pembrolizumab - Concurrent041
otherAcute coronary syndromeCardiac disordersCisplatin + Radiation + Pembrolizumab - Sequential139
otherAortic valve diseaseCardiac disordersCisplatin + Radiation + Pembrolizumab - Concurrent041
otherAortic valve diseaseCardiac disordersCisplatin + Radiation + Pembrolizumab - Sequential139
otherAtrial fibrillationCardiac disordersCisplatin + Radiation + Pembrolizumab - Concurrent141
otherAtrial fibrillationCardiac disordersCisplatin + Radiation + Pembrolizumab - Sequential039
otherCardiac disorders - Other, specifyCardiac disordersCisplatin + Radiation + Pembrolizumab - Concurrent041
otherCardiac disorders - Other, specifyCardiac disordersCisplatin + Radiation + Pembrolizumab - Sequential139
otherCardiac disorders - Other, specifyBradycardiaCardiac disordersCisplatin + Radiation + Pembrolizumab - Concurrent141
otherCardiac disorders - Other, specifyBradycardiaCardiac disordersCisplatin + Radiation + Pembrolizumab - Sequential039
otherCardiac disorders - Other, specifyCADCardiac disordersCisplatin + Radiation + Pembrolizumab - Concurrent141
otherCardiac disorders - Other, specifyCADCardiac disordersCisplatin + Radiation + Pembrolizumab - Sequential039
otherCardiac disorders - Other, specifyCoronary artery calcificationsCardiac disordersCisplatin + Radiation + Pembrolizumab - Concurrent141
otherCardiac disorders - Other, specifyCoronary artery calcificationsCardiac disordersCisplatin + Radiation + Pembrolizumab - Sequential039

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02777385/events